UGC Approved Journal no 63975(19)

ISSN: 2349-5162 | ESTD Year : 2014
Call for Paper
Volume 11 | Issue 10 | October 2024

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 10 Issue 8
August-2023
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2308567


Registration ID:
523739

Page Number

f573-f581

Share This Article


Jetir RMS

Title

ADVERSE DRUG REACTIONS OF ANTI-DIABETIC MEDICATIONS

Abstract

Abstract Adverse drug reactions (ADRs) continue to be a problem in modern medicine, especially in light of the complexity of therapies, the ageing of the population, and the rise in multimorbidity. Due to an increase in the number of new drug classes, studies have also revealed that admitted patients have a higher frequency of ADR. ADRs accounted for 6.2% of hospitalisations and 3.2% of ADRs during hospitalisation, per an Indian study. Sulphonylureas, thiazolidinediones, alpha-glucosidase inhibitors, and biguanides are diabetes medications that have significant ADR. Compared to patients receiving monotherapy, ADRs are manifested more frequently in patients receiving combo medication. Though there are no absolute contraindications to insulin therapy, the dose of insulin needs to be adjusted and monitored in numerous settings. The most common adverse drug reactions of metformin were lactic acidosis followed by hypoglycemia, hypersensitivity reactions, nausea, decreased appetite, vomiting, weakness, and diarrhoea. Thiazolidinediones have a few negative side effects, especially with prolonged use. Even while some ADRs are unanticipated, like anaphylaxis in a patient after a single uneventful exposure to a penicillin-containing drug, many may be avoided with enough planning and monitoring. However, reducing the likelihood of an ADR happening can be a significant method to lessen the risk of patient damage. Therefore, raising public awareness of the negative effects of anti-diabetic medications is necessary in the modern period. The Pharmacists play a vital role in monitoring ADR, educating the health care team and designing the medication chart. Thus, it is highly significant to frame a systematic protocol in ADR monitoring and managing them.

Key Words

Index Terms: Adverse drug reactions, anti-diabetic medications, hypersensitivity, absolute contraindications, uneventful exposure, ADR monitoring

Cite This Article

"ADVERSE DRUG REACTIONS OF ANTI-DIABETIC MEDICATIONS", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.10, Issue 8, page no.f573-f581, August-2023, Available :http://www.jetir.org/papers/JETIR2308567.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"ADVERSE DRUG REACTIONS OF ANTI-DIABETIC MEDICATIONS", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.10, Issue 8, page no. ppf573-f581, August-2023, Available at : http://www.jetir.org/papers/JETIR2308567.pdf

Publication Details

Published Paper ID: JETIR2308567
Registration ID: 523739
Published In: Volume 10 | Issue 8 | Year August-2023
DOI (Digital Object Identifier):
Page No: f573-f581
Country: NAMAKKAL, TAMILNADU, India .
Area: Pharmacy
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

000114

Print This Page

Current Call For Paper

Jetir RMS